Browse > Article
http://dx.doi.org/10.4048/jbc.2012.15.2.141

Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by 2-Deoxy-D-Glucose in Combination Therapy  

Aghaee, Fahimeh (Department of Medical Physics, Tabriz University of Medical Sciences School of Medicine)
Islamian, Jalil Pirayesh (Department of Medical Physics, Tabriz University of Medical Sciences School of Medicine)
Baradaran, Behzaad (Department of Immunology, Tabriz University of Medical Sciences School of Medicine)
Publication Information
Journal of Breast Cancer / v.15, no.2, 2012 , pp. 141-147 More about this Journal
Abstract
Breast cancer is the most common malignancy, and it is also the major cause of cancer-related deaths of women worldwide. Breast cancer treatment involves surgery, chemotherapy, radiation therapy, or combination therapy, and novel strategies are needed to boost the oncologic outcome. The non-metabolizable glucose analogue, 2-deoxy-D-glucose (2-DG) which inhibits glucose synthesis and adenosine triphosphate production, is one of the important discoveries involving the disturbances that can be caused to the process of the metabolism. The glucose analogue, 2-DG, is known as a tumor sensitizer to irradiation (IR) and chemotherapy, which help improve the treatment rates. It enhances the cytotoxicity via oxidative stress, which is more redundant in tumor cells than in normal ones. This article provides a brief summary on studies related to 2-DG chemo-/radio-sensitization effects by combination therapy of 2-DG/IR or 2-DG/doxorubicin.
Keywords
2-deoxy-D-glucose; Breast neoplasms; Combined modality therapy; Radiation; Tumor cell line;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Genetics of breast cancer for the practicing surgeon. Agashe PP, Shrikhande SV. http://www.bhj.org/journal/2001_4304_oct/review_537.htm. Accessed June 12th, 2011.
2 Types of breast cancer: ER positive, HER2 positive, and triple negative. WebMD. http://www.webmd.com/breast-cancer/breast-cancer-typeser- positive-her2-positive. Accessed August 2nd, 2010.
3 Breast cancer: tumor biology. Winship Cancer Institute. http://www. cancerquest.org/breast-cancer-molecular-biology. Accessed August 4th, 2010.
4 Aft RL, Zhang FW, Gius D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer 2002;87: 805-12.   DOI
5 Maher JC, Krishan A, Lampidis TJ. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother Pharmacol 2004;53:116-22.   DOI
6 Sinthupibulyakit C, Grimes KR, Domann FE, Xu Y, Fang F, Ittarat W, et al. p53 is an important factor for the radiosensitization effect of 2-deoxy- D-glucose. Int J Oncol 2009;35:609-15.
7 Ahmad IM, Mustafa EH, Mustafa NH, Tahtamouni LH, Abdalla MY. 2DG enhances the susceptibility of breast cancer cells to doxorubicin. Cent Eur J Biol 2010;5:739-48.
8 Zhang F, Aft RL. Chemosensitizing and cytotoxic effects of 2-deoxy-Dglucose on breast cancer cells. J Cancer Res Ther 2009;5 Suppl 1:S41-3.
9 Kalia VK, Prabhakara S, Narayanan V. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy. J Cancer Res Ther 2009;5 Suppl 1:S57-60.   DOI
10 Dwarakanath BS. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro. J Cancer Res Ther 2009;5 Suppl 1:S27-31.   DOI
11 Spitz DR, Sim JE, Ridnour LA, Galoforo SS, Lee YJ. Glucose deprivation- induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci 2000;899:349-62.
12 Han W, Kang SY; Korean Breast Cancer Society. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 2010;119:193-200.   DOI
13 Rodeh HJ, Eisel D, Frost I. Apoptosis, Cell Death and Cell Proliferation. 3rd ed. Mannheim: Roche Diagnostics GmbH; 2000. p.2-6.
14 Cobb JP, Hotchkiss RS, Karl IE, Buchman TG. Mechanisms of cell injury and death. Br J Anaesth 1996;77:3-10.   DOI
15 Ghilotti M, Pierotti MA, Gariboldi M. Molecular markers for prediction of risk of radiation-related injury to normal tissue. J Nucleic Acids Investig 2010;1:55-61.
16 Dwarkanath BS, Zolzer F, Chandana S, Bauch T, Adhikari JS, Muller WU, et al. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Int J Radiat Oncol Biol Phys 2001;50:1051-61.   DOI
17 Schwarz SB, Schaffer PM, Kulka U, Ertl-Wagner B, Hell R, Schaffer M. The effect of radio-adaptive doses on HT29 and GM637 cells. Radiat Oncol 2008;3:12.   DOI
18 Mohanti BK, Rath GK, Anantha N, Kannan V, Das BS, Chandramouli BA, et al. Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys 1996;35:103-11.
19 Kunigal S, Lakka SS, Joseph P, Estes N, Rao JS. Matrix metalloproteinase- 9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors. Clin Cancer Res 2008; 14:3617-26.   DOI
20 Gupta S, Farooque A, Adhikari JS, Singh S, Dwarakanath BS. Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy- D-glucose in animal tumors. J Cancer Res Ther 2009;5 Suppl 1:S16-20.   DOI
21 Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006;25:4633-46.   DOI
22 Elstner E, Williamson EA, Zang C, Fritz J, Heber D, Fenner M, et al. Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells. Breast Cancer Res Treat 2002;74:155-65.   DOI
23 Kaabinejadian S, Fouladdel SH, Ramezani M, Azizi E. p53 expression in MCF7, T47D and MDA-MB 468 breast cancer cell lines treated with adriamycin using RT-PCR and immunocytochemistry. J Biol Sci 2008; 8:380-5.   DOI
24 de la Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 1993;341:1039-43.   DOI
25 Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J 2009; 418:29-37.   DOI
26 Warburg O. On the origin of cancer cells. Science 1956;123:309-14.   DOI
27 Butt AJ, Firth SM, King MA, Baxter RC. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 2000;275:39174-81.   DOI
28 Simons AL, Ahmad IM, Mattson DM, Dornfeld KJ, Spitz DR. 2-Deoxy- D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res 2007; 67:3364-70.   DOI
29 Jain VK, Kalia VK, Sharma R, Maharajan V, Menon M. Effects of 2-deoxy- D-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells. Int J Radiat Oncol Biol Phys 1985;11:943-50.   DOI
30 Knowlton K, Mancini M, Creason S, Morales C, Hockenbery D, Anderson BO. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect. J Surg Res 1998;76:22-6.   DOI
31 Ahmad IM, Abdalla MY, Aykin-Burns N, Simons AL, Oberley LW, Domann FE, et al. 2-Deoxyglucose combined with wild-type p53 overexpression enhances cytotoxicity in human prostate cancer cells via oxidative stress. Free Radic Biol Med 2008;44:826-34.   DOI
32 Singh G, Lakkis CL, Laucirica R, Epner DE. Regulation of prostate cancer cell division by glucose. J Cell Physiol 1999;180:431-8.   DOI
33 Zhao Y, Liu H, Liu Z, Ding Y, LeDoux SP, Wilson GL, et al. Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res 2011;71:4585-97.   DOI